Envista Holdings Corporation (NYSE: NVST) stock is soaring 5.60% in pre-market trading on Friday following the release of its first-quarter 2025 earnings report. The dental products company reported adjusted earnings per share of $0.24, slightly above analysts' expectations, despite facing challenges in the global dental market.

The company's Q1 revenue came in at $617 million, with a core growth of 0.2%. Despite a decrease in adjusted gross margin and currency exchange headwinds, Envista maintained its 2025 guidance of 1% to 3% core growth, approximately 14% adjusted EBITDA margins, and adjusted EPS of $0.95 to $1.05. This show of confidence in the face of market uncertainties appears to be driving investor optimism.

Adding to the positive sentiment, several analysts have adjusted their price targets for Envista Holdings. Notably, Leerink Partners raised its target price to $18.5 from $18, signaling confidence in the company's prospects. However, JP Morgan cut its target price to $17 from $19, highlighting the mixed views in the market. The company's ability to navigate challenges such as tariff impacts and volume-based procurement in China, as discussed in the earnings call, seems to be resonating well with investors.